Effects of a SARS-associated coronavirus vaccine in monkeys

Lancet

Volumn 362, Issue 9399, 2003, Pages 1895-1896

  Gao, Wentao ^a   Tamin, Azaibi ^c   Soloff, Adam ^b   D'Aiuto, Leonardo ^a   Nwanegbo, Edward ^a   Robbins, Paul D ^a   Bellini, William J ^c   Barratt Boyes, Simon ^b   Gambotto, Andrea ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c NATL CENTER FOR INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; SEVERE ACUTE RESPIRATORY SYNDROME VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CODON; CONTROLLED STUDY; MONKEY; NONHUMAN; PRIORITY JOURNAL; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; T LYMPHOCYTE; VACCINATION; VIRUS IMMUNITY;

EID: 0345549412     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14962-8     Document Type: Article

References (5)

1. Rota P.A., Oberste M.S., Monroe S.S., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science. 300:2003;1394-1399.
2. Anton I.M., Gonzalez S., Bullido M.J., et al. Cooperation between transmissible gastroenteritis coronavirus (TGEV) structural proteins in the in vitro induction of virus-specific antibodies. Virus Res. 46:1996;111-124.
3. Brown K, Gao W, Alber S, et al. Adenovirus-transduced dendritic cells injected into skin or lymph node prime potent siv-specific t-cell immunity in monkeys. J Immunol (in press).
4. Weiss R.C., Scott W. Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis. 4:1981;175-189.
5. Fouchier R.A., Kuiken T., Schutten M., et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature. 423:2003;240.